CROSBY Research – Telecom Sector: Stringent capex control after 5G buildout peaked, telco’s key focus is on computing power for Cloud and AI usage
16 Apr 2024 According to the latest data...
CROSBY Research – Wasion Holdings (3393 HK/BUY): Securing State Grid’s first FY24 tender
16 Apr 2024 Wasion announced the first b...
CROSBY Research – YesAsia (2209 HK): Riding on the growing K-Beauty popularity
09 Apr 2024 YesAsia’s FY23 revenue incre...
CROSBY Research – EVA Holdings (838 HK): Auto equipment drove FY23 growth
08 Apr 2024 Facing the on-going uncertai...
CROSBY Research – China Lesso (2128 HK/BUY): New business venture to foster future growth
05 Apr 2024 2023 was a recovery year for...
CROSBY Research – Xiabuxiabu (520 HK/BUY): FY23 net loss narrowed on higher revenue and GPM
05 Apr 2024 Xiabu’s FY23 revenue was up...
CROSBY Research – China Suntien Green Energy (956 HK/BUY): Increasing capex in FY24
02 Apr 2024 FY23 revenue was up by 9.3%...
CROSBY Research – Anta Sports (2020 HK/BUY): FY23 NP up by 35% YoY, better than expected
28 Mar 2024 Anta’s FY23 revenue was up b...
CROSBY Research – Canvest Environmental (1381 HK/BUY): Topline down 40% on fewer construction projects
27 Mar 2024 FY23 revenue decreased by 39...
CROSBY Research – Natural Food International (1837 HK/BUY): Better than expected FY23 results
27 Mar 2024 NFI’s FY23 topline was up by...
CROSBY Research – Q-Tech (1478 HK/BUY): Revenue growth turned around and GPM bottomed out in 2H23; expect product mix improvement persist into FY24
27 Mar 2024 After three consecutive decl...
CROSBY Research – WL Delicious (9985 HK): Expects a >15% YoY sales growth in FY24
25 Mar 2024 WL Delicious ‘s FY23 revenue...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)
25 Mar 2024 According to Reuters, China...
CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise
25 Mar 2024 After four consecutive decli...
CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio
25 Mar 2024 Tai Hing’s FY23 revenue incr...
CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23
21 Mar 2024 Vincent Medical’s FY23 turno...
CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst
21 Mar 2024 Xiaomi reported 4Q23 results...
CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability
19 Mar 2024 Xtep’s FY23 revenue was up b...
CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24
19 Mar 2024 The company reported a 14.8%...
CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement
18 Mar 2024 Following the positive profi...